New Nanoparticles Generate Hydrogen to Treat Rheumatoid Arthritis
- Authors
- Minghao Chao, Yuqi Huang, Peng Zhou, Guoquan Wu, Yiping Ren, Hanrong Yan, Shuqing Dong, Xiang Yan, Hongliang Chen, Fenglei Gao
- Journal
- International Journal of Biological Macromolecules
- Year
- 2024
- DOI
- 10.1016/j.ijbiomac.2024.135929
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Rheumatoid Arthritis
- Body System
- Musculoskeletal
TL;DR
Scientists have created a new type of tiny particle that can produce healing hydrogen and gently warm up to treat rheumatoid arthritis without causing inflammation.
Key Finding
In cell and animal studies, the engineered nanoparticle successfully generated hydrogen gas under light exposure and reduced inflammation while triggering death of abnormal synovial cells, suggesting a dual therapeutic mechanism for rheumatoid arthritis.
Summary
Researchers developed a special nanoparticle (tiny engineered material) that can generate hydrogen gas when exposed to specific light, with the goal of treating rheumatoid arthritis—a chronic inflammatory joint disease. The nanoparticle was tested in cell cultures and animal models to see if it could reduce inflammation and kill abnormal cells in the joints through a combination of hydrogen production and mild heat therapy.
Practical Takeaway
This is very early-stage research conducted only in cell cultures and animal models—not yet tested in humans. While the results are promising for a novel approach to arthritis treatment, it remains a laboratory concept with no established safety or effectiveness in people. Much more research would be needed before any clinical application.
Abstract
Rheumatoid arthritis, characterized by the abnormal proliferation of synovial cells and extensive macrophage infiltration, is a chronic inflammatory disease. Molecular hydrogen, known for its antioxidant properties, has shown promise in eliminating reactive oxygen species. However, the low solubility and bioavailability of hydrogen limit the effectiveness of this therapy. To overcome these issues, we developed a novel yolk-shell heterostructure, H-AAZS (Au/Ag@ZnS modified hyaluronic acid), utilizing a hydrothermal cation exchange process. Through ion doping, semiconductor hybridization, and Schottky barriers in H-AAZS, photocatalysis for hydrogen generation has been successfully implemented using 660 nm laser irradiation. Additionally, the H-AAZS demonstrate the capacity for mild photothermal therapy, inducing apoptosis in synovial cells with Au's hot electrons with 660 nm laser irradiation. This strategy not only improves the abnormal proliferation of synovial cells but also avoids the exacerbation of inflammation caused by thermal stimulation. Both in vitro and in vivo experiments validate the synergistic effects of hydrogen production mediated anti-inflammatory responses, macrophage polarization and photothermal therapy. Therefore, this work represents a significant advancement as it ingeniously harnesses photocatalysis to modulate the synovial microenvironment while mitigating the side effects associated with photothermal therapy. This nanocrystal provides new and valuable insights into the potential treatment of Rheumatoid arthritis.